Word

ENPC

Status

Registered

Status Code

700

Status Date

Tuesday, March 17, 2020

Serial Number

88278768

Registration Number

6011047

Registration Date

Tuesday, March 17, 2020

Mark Type

4000

Filing Date

Monday, January 28, 2019

Published for Opposition

Tuesday, December 31, 2019

Trademark Owner History

NEUWAY Pharma GmbH - Original Registrant

Classifications

40 manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties

5 Diagnostic preparations for medical and veterinary use; vaccines; pharmaceutical preparations, in particular adjuvants, carriers for active ingredients and drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents consisting of proteins in the form of capsids or particles for medical use in humans or animals, biological implants comprising active ingredients for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation

1 Chemical, biological, biochemical and biotechnological products and preparations, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof for laboratory or research use and manufacturing use

42 Scientific research and development for third parties, namely, in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development with regard to the manufacture of pharmaceutical preparations, carriers for active ingredients and drug delivery systems for use in humans or animals, for third parties; development of pharmaceutical preparations, namely, medical products, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation for others

Trademark Events

Apr 26, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Apr 26, 2022

Teas Change Of Correspondence Received

Apr 26, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Apr 26, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 26, 2022

Teas Change Of Owner Address Received

Mar 17, 2020

Registered-Principal Register

Dec 31, 2019

Official Gazette Publication Confirmation E-Mailed

Dec 31, 2019

Published For Opposition

Dec 11, 2019

Notification Of Notice Of Publication E-Mailed

Nov 25, 2019

Approved For Pub - Principal Register

Nov 5, 2019

Teas/Email Correspondence Entered

Nov 5, 2019

Correspondence Received In Law Office

Oct 31, 2019

Teas Response To Suspension Inquiry Received

Oct 28, 2019

Notification Of Letter Of Suspension E-Mailed

Oct 28, 2019

Letter Of Suspension E-Mailed

Oct 28, 2019

Suspension Letter Written

Oct 7, 2019

Teas/Email Correspondence Entered

Oct 7, 2019

Correspondence Received In Law Office

Oct 4, 2019

Teas Response To Office Action Received

Oct 4, 2019

Teas Withdrawal Of Attorney Received-Firm Retains

Aug 27, 2019

Notification Of Non-Final Action E-Mailed

Aug 27, 2019

Non-Final Action E-Mailed

Aug 27, 2019

Non-Final Action Written

Jun 12, 2019

Teas Change Of Correspondence Received

Apr 12, 2019

Notification Of Non-Final Action E-Mailed

Apr 12, 2019

Non-Final Action E-Mailed

Apr 12, 2019

Non-Final Action Written

Apr 9, 2019

Assigned To Examiner

Feb 25, 2019

Preliminary/Voluntary Amendment - Entered

Feb 21, 2019

Assigned To Lie

Feb 20, 2019

New Application Office Supplied Data Entered In Tram

Feb 14, 2019

Teas Voluntary Amendment Received

Jan 31, 2019

New Application Entered In Tram